FOLD   $14.41  -0.14% Market Open

Amicus Therapeutics, Inc.
Total Cash 260.06M
totalCashPerShare 0.877
EBITDA -16.68M
Total Debt 444.06M
quickRatio 2.054
currentRatio 2.747
Total Revenue 455.66M
debtToEquity 335.08
Revenue/Share 1.515
ROA -0.02148
ROE -0.97939
grossProfits
freeCashflow 12.99M
operatingCashflow -41.89M
earningsGrowth
revenueGrowth 0.34
grossMargins 0.89883006
ebitdaMargins -0.03661
operatingMargins 0.11816
profitMargins -0.26233998
enterpriseValue 3.67B
forwardPE 59.157894
floatShares 238.86M
sharesOutstanding 296.59M
sharesShort 21.94M
sharesShortPriorMonth 22.81M
dateShortInterest
sharesPercentSharesOut 0.07%
heldPercentInsiders 0.01%
heldPercentInstitutions 1.07%
Short Ratio help_outline 9.51%
shortPercentOfFloat 0.07%
impliedSharesOutstanding
bookValue 0.546
Price To Book help_outline 20.59
earningsQuarterlyGrowth
netIncomeToCommon -119.54M
trailingEps -0.37%
forwardEps 0.18%
enterpriseToEbitda -219.74
lastDividendValue
lastDividendDate
currentQuarterEstimate 0.0 3Q 2024
institutionsCount 352
lastUpdated Nov. 7, 2024, 9:26 a.m.